Download PDF
J Knee Surg 2021; 34(09): 941-951
DOI: 10.1055/s-0039-1700979
Original Article

Simultaneous Bilateral Total Knee Arthroplasty Becomes Safer after Institution of Optimal Perioperative Management: A Longitudinal Cohort Study

Shih-Hao Chen
1   Department of Orthopaedic Surgery, Buddhist Tzu-Chi Hospital at Taichung, Taiwan
2   Department of Orthopaedics, Tzu-Chi University, Hualien, Taiwan
,
Jen-Yuh Chen
3   Postal Hospital, Taipei, Taiwan
4   Department of Orthopaedics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
5   Department of Orthopedics, Taipei Medical University Hospital, Taipei, Taiwan
,
Tze-Hong Wong 
6   Department of Orthopedics, National Taiwan University Hospital, Hsin Chu Branch, HsinChu, Taiwan
,
Frederick Buechel Jr.
4   Department of Orthopaedics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
7   Department of Orthopaedic Surgery, Lenox Hill Hospital, New York
8   Robotic Joint Center, New York
,
Meng-Huang Wu 
3   Postal Hospital, Taipei, Taiwan
4   Department of Orthopaedics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
5   Department of Orthopedics, Taipei Medical University Hospital, Taipei, Taiwan
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Simultaneous bilateral total knee arthroplasty (SBTKA) increases the rates of procedure-related complications and mortality compared with unilateral TKA. There are no well-defined guidelines for selecting patients to avoid mortality and proposing an upgrade treatment to decrease complication rates. This study aimed to evaluate whether optimal perioperative management could improve the safety of SBTKA. From 2005 to 2017, 1,166 cases of SBTKA were identified from 14,209 TKA procedures. We retrospectively examined the SBTKA patients' demographics, comorbidity profiles, procedure-related complications, and perioperative management during two time periods. Optimal perioperative workup for managing SBTKA significantly decreased the incidences of major complication from 6.2 to 2.4% (p = 0.001) and minor complications from 28.9 to 21.5% (p = 0.004) during period I and period II, respectively. The efficiency of less tourniquet use along with intraarticular tranexamic acid injection was demonstrated by the decreases of hemoglobin (Hb) change in the first 2 days after surgery (p = 0.005) and blood transfusion requirement (p = 0.035) during the SBTKA. Furthermore, the less tourniquet use group had less thigh pain (visual analog scale decreased from 6.0 to 4.2, p = 0.003), shorter duration of hospital stay (decreased from 7.8 to 7.1, p < 0.001), and lower coagulation time (decrease from 3.5 to 2.9, p < 0.001) than the routine tourniquet use group. Patient's screening must be performed carefully for cardiopulmonary compromise in patients aged >80 years and with an American Society of Anesthesiologists score of 3. Additionally, hospitalists should consider developing methods for the eligibility, testing, and perioperative monitoring of patients who undergo SBTKA with the aim of avoiding complications and improving outcomes.

Keywords

simultaneous bilateral total knee arthroplasty - patient selection - perioperative management - complication - tourniquet use


Publication History

Received: 09 April 2019

Accepted: 27 November 2019

Article published online:
17 January 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Ritter MA, Harty LD, Davis KE, Meding JB, Berend M. Simultaneous bilateral, staged bilateral, and unilateral total knee arthroplasty. A survival analysis. J Bone Joint Surg Am 2003; 85 (08) 1532-1537
    CrossrefPubMedGoogle Scholar
  • 2 Memtsoudis SG, Hargett M, Russell LA. et al; Consensus Conference on Bilateral Total Knee Arthroplasty Group. Consensus statement from the consensus conference on bilateral total knee arthroplasty group. Clin Orthop Relat Res 2013; 471 (08) 2649-2657
    CrossrefPubMedGoogle Scholar
  • 3 Poultsides L, Memtsoudis S, Gonzalez Della Valle A. et al. Perioperative morbidity and mortality of same-day bilateral TKAs: incidence and risk factors. Clin Orthop Relat Res 2014; 472 (01) 111-120
    CrossrefPubMedGoogle Scholar
  • 4 Meehan JP, Danielsen B, Tancredi DJ, Kim S, Jamali AA, White RH. A population-based comparison of the incidence of adverse outcomes after simultaneous-bilateral and staged-bilateral total knee arthroplasty. J Bone Joint Surg Am 2011; 93 (23) 2203-2213
    CrossrefPubMedGoogle Scholar
  • 5 Odum SM, Springer BD. In-hospital complication rates and associated factors after simultaneous bilateral versus unilateral total knee arthroplasty. J Bone Joint Surg Am 2014; 96 (13) 1058-1065
    CrossrefPubMedGoogle Scholar
  • 6 Bullock DP, Sporer SM, Shirreffs Jr TG. Comparison of simultaneous bilateral with unilateral total knee arthroplasty in terms of perioperative complications. J Bone Joint Surg Am 2003; 85 (10) 1981-1986
    CrossrefPubMedGoogle Scholar
  • 7 Yoon HS, Han CD, Yang IH. Comparison of simultaneous bilateral and staged bilateral total knee arthroplasty in terms of perioperative complications. J Arthroplasty 2010; 25 (02) 179-185
    CrossrefPubMedGoogle Scholar
  • 8 Cahill CW, Schwarzkopf R, Sinha S, Scott RD. Simultaneous bilateral knee arthroplasty in octogenarians: can it be safe and effective?. J Arthroplasty 2014; 29 (05) 998-1000
    CrossrefPubMedGoogle Scholar
  • 9 Noble J, Goodall JR, Noble DJ. Simultaneous bilateral total knee replacement: a persistent controversy. Knee 2009; 16 (06) 420-426
    CrossrefPubMedGoogle Scholar
  • 10 Restrepo C, Parvizi J, Dietrich T, Einhorn TA. Safety of simultaneous bilateral total knee arthroplasty. A meta-analysis. J Bone Joint Surg Am 2007; 89 (06) 1220-1226
    CrossrefPubMedGoogle Scholar
  • 11 Urban MK, Chisholm M, Wukovits B. Are postoperative complications more common with single-stage bilateral (SBTKR) than with unilateral knee arthroplasty: guidelines for patients scheduled for SBTKR. HSS J 2006; 2 (01) 78-82
    CrossrefPubMedGoogle Scholar
  • 12 Hasanain MS, Apostu D, Alrefaee A, Tarabichi S. Comparing the effect of tourniquet vs tourniquet-less in simultaneous bilateral total knee arthroplasties. J Arthroplasty 2018; 33 (07) 2119-2124
    CrossrefPubMedGoogle Scholar
  • 13 Bagsby DT, Samujh CA, Vissing JL, Empson JA, Pomeroy DL, Malkani AL. Tranexamic acid decreases incidence of blood transfusion in simultaneous bilateral total knee arthroplasty. J Arthroplasty 2015; 30 (12) 2106-2109
    CrossrefPubMedGoogle Scholar
  • 14 Prieto HA, Vincent HK, Deen JT, Iams DA, Parvataneni HK. Tranexamic acid effectively reduces blood loss and transfusion rates during simultaneous bilateral total knee arthroplasty. J Knee Surg 2018; 31 (03) 270-276
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Marya SK, Amit P, Singh C. Impact of Charlson indices and comorbid conditions on complication risk in bilateral simultaneous total knee arthroplasty. Knee 2016; 23 (06) 955-959
    CrossrefPubMedGoogle Scholar
  • 16 Koh IJ, Kim GH, Kong CG, Park SW, Park TY, In Y. The patient's age and american society of anesthesiologists status are reasonable criteria for deciding whether to perform same-day bilateral TKA. J Arthroplasty 2015; 30 (05) 770-775
    CrossrefPubMedGoogle Scholar
  • 17 Fleisher LA, Beckman JA, Brown KA. et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009; 120 (21) e169-e276
    PubMedGoogle Scholar
  • 18 Lin AC, Chao E, Yang CM, Wen HC, Ma HL, Lu TC. Costs of staged versus simultaneous bilateral total knee arthroplasty: a population-based study of the Taiwanese National Health Insurance Database. J Orthop Surg Res 2014; 9: 59
    CrossrefPubMedGoogle Scholar
  • 19 Clement ND, MacDonald D, Howie CR, Biant LC. The outcome of primary total hip and knee arthroplasty in patients aged 80 years or more. J Bone Joint Surg Br 2011; 93 (09) 1265-1270
    CrossrefPubMedGoogle Scholar
  • 20 Joshi AB, Markovic L, Gill G. Knee arthroplasty in octogenarians: results at 10 years. J Arthroplasty 2003; 18 (03) 295-298
    CrossrefPubMedGoogle Scholar
  • 21 Kennedy JW, Johnston L, Cochrane L, Boscainos PJ. Total knee arthroplasty in the elderly: does age affect pain, function or complications?. Clin Orthop Relat Res 2013; 471 (06) 1964-1969
    CrossrefPubMedGoogle Scholar
  • 22 Easterlin MC, Chang DG, Talamini M, Chang DC. Older age increases short-term surgical complications after primary knee arthroplasty. Clin Orthop Relat Res 2013; 471 (08) 2611-2620
    CrossrefPubMedGoogle Scholar
  • 23 Kuo FC, Hsu CH, Chen WS, Wang JW. Total knee arthroplasty in carefully selected patients aged 80 years or older. J Orthop Surg Res 2014; 9: 61
    CrossrefPubMedGoogle Scholar
  • 24 Barrett J, Baron JA, Losina E, Wright J, Mahomed NN, Katz JN. Bilateral total knee replacement: staging and pulmonary embolism. J Bone Joint Surg Am 2006; 88 (10) 2146-2151
    PubMedGoogle Scholar
  • 25 Kim GH, Park BY, Bae TY, Kang JW, In Y. Can enoxaparin reduce thromboembolism related events after primary TKA in Asian patients?. J Arthroplasty 2013; 28 (10) 1862-1867
    CrossrefPubMedGoogle Scholar
  • 26 Wang CJ, Wang JW, Weng LH, Hsu CC, Huang CC, Yu PC. Prevention of deep-vein thrombosis after total knee arthroplasty in Asian patients. Comparison of low-molecular-weight heparin and indomethacin. J Bone Joint Surg Am 2004; 86 (01) 136-140
    CrossrefPubMedGoogle Scholar
  • 27 Yeager AM, Ruel AV, Westrich GH. Are bilateral total joint arthroplasty patients at a higher risk of developing pulmonary embolism following total hip and knee surgery?. J Arthroplasty 2014; 29 (05) 900-902
    CrossrefPubMedGoogle Scholar
  • 28 Chung LH, Chen WM, Chen CF, Chen TH, Liu CL. Deep vein thrombosis after total knee arthroplasty in asian patients without prophylactic anticoagulation. Orthopedics 2011; 34 (01) 15
    CrossrefPubMedGoogle Scholar
  • 29 Leizorovicz A. ; SMART Venography Study Steering Committee. Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography study. Haematologica 2007; 92 (09) 1194-1200
    CrossrefPubMedGoogle Scholar
  • 30 Tsukada S, Wakui M. Combined intravenous and intra-articular tranexamic acid in simultaneous bilateral total knee arthroplasty without tourniquet use. JBJS 2017; 2 (02) 0002
    PubMedGoogle Scholar
  • 31 Kim HJ, Walcott-Sapp S, Leggett K. et al. Detection of pulmonary embolism in the postoperative orthopedic patient using spiral CT scans. HSS J 2010; 6 (01) 95-98
    CrossrefPubMedGoogle Scholar
  • 32 Turpie AG, Esmon C. Venous and arterial thrombosis--pathogenesis and the rationale for anticoagulation. Thromb Haemost 2011; 105 (04) 586-596
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Falck-Ytter Y, Francis CW, Johanson NA. et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141 (2, Suppl) e278S-e325S
    CrossrefPubMedGoogle Scholar
  • 34 Mont MA, Jacobs JJ, Boggio LN. et al; AAOS. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg 2011; 19 (12) 768-776
    CrossrefPubMedGoogle Scholar
  • 35 Bawa H, Weick JW, Dirschl DR, Luu HH. Trends in deep vein thrombosis prophylaxis and deep vein thrombosis rates after total hip and knee arthroplasty. J Am Acad Orthop Surg 2018; 26 (19) 698-705
    CrossrefPubMedGoogle Scholar
  • 36 Gómez-Outes A, Terleira-Fernández AI, Suárez-Gea ML, Vargas-Castrillón E. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. BMJ 2012; 344: e3675
    CrossrefPubMedGoogle Scholar
  • 37 Parvizi J, Sullivan TA, Trousdale RT, Lewallen DG. Thirty-day mortality after total knee arthroplasty. J Bone Joint Surg Am 2001; 83 (08) 1157-1161
    CrossrefPubMedGoogle Scholar
  • 38 Wang JW, Chen B, Lin PC, Yen SH, Huang CC, Kuo FC. The efficacy of combined use of rivaroxaban and tranexamic acid on blood conservation in minimally invasive total knee arthroplasty a double-blind randomized, controlled trial. J Arthroplasty 2017; 32 (03) 801-806
    CrossrefPubMedGoogle Scholar
  • 39 Kim YT, Kang MW, Lee JK, Lee YM, Kim JI. Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis. BMC Musculoskelet Disord 2018; 19 (01) 227
    CrossrefPubMedGoogle Scholar
  • 40 Nishihara S, Hamada M. Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis?. Bone Joint J 2015; 97-B (04) 458-462
    CrossrefPubMedGoogle Scholar
  • 41 Alcelik I, Pollock RD, Sukeik M, Bettany-Saltikov J, Armstrong PM, Fismer P. A comparison of outcomes with and without a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty 2012; 27 (03) 331-340
    CrossrefPubMedGoogle Scholar
  • 42 Rama KR, Apsingi S, Poovali S, Jetti A. Timing of tourniquet release in knee arthroplasty. Meta-analysis of randomized, controlled trials. J Bone Joint Surg Am 2007; 89 (04) 699-705
    CrossrefPubMedGoogle Scholar
  • 43 Tai TW, Chang CW, Lai KA, Lin CJ, Yang CY. Effects of tourniquet use on blood loss and soft-tissue damage in total knee arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 2012; 94 (24) 2209-2215
    CrossrefPubMedGoogle Scholar
  • 44 Kim TK, Chang CB, Kang YG. et al. Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 2014; 22 (08) 1870-1878
    CrossrefPubMedGoogle Scholar
  • 45 Bossone E, D'Andrea A, D'Alto M. et al. Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr 2013; 26 (01) 1-14
    CrossrefPubMedGoogle Scholar
  • 46 Jules-Elysee KM, YaDeau JT, Urban MK. Pulmonary artery versus central venous catheter monitoring in the outcome of patients undergoing bilateral total knee replacement. HSS J 2009; 5 (01) 27-30
    CrossrefPubMedGoogle Scholar
  • 47 Davidson BL, Verheijen S, Lensing AW. et al. Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin. JAMA Intern Med 2014; 174 (06) 947-953
    CrossrefPubMedGoogle Scholar
  • 48 Friedman RJ, Kurth A, Clemens A, Noack H, Eriksson BI, Caprini JA. Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding. Thromb Haemost 2012; 108 (01) 183-190
    Article in Thieme ConnectPubMedGoogle Scholar
  • 49 Wong E, Nguyen CL, Park S, Parker D. Simultaneous, same-anaesthetic bilateral total knee arthroplasty has low mortality and complication rates. Knee Surg Sports Traumatol Arthrosc 2018; 26 (11) 3395-3402
    CrossrefPubMedGoogle Scholar
  • 50 Kulshrestha V, Kumar S, Datta B, Sinha VK, Mittal G. Ninety-day morbidity and mortality in risk-screened and optimized patients undergoing two-team fast-track simultaneous bilateral TKA compared with unilateral TKA-A prospective study. J Arthroplasty 2018; 33 (03) 752-760
    CrossrefPubMedGoogle Scholar